Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | SI | P14410 | 2/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2071447 | 0.73 | HTR2C (0.50) | GPR84FFAR1SRCMAPTNR3C1 | |
| SCHEMBL2071514 | 0.72 | GPR84 (0.49) | GPR84FFAR1SRCMAPTNR3C1 | |
| SCHEMBL21479835 | 0.71 | GPR84 (0.58) | GPR84FFAR1SRCMAPTNR3C1 | |
| SCHEMBL29871975 | 0.70 | GPR84 (0.53) | GPR84FFAR1MAPTHTR2AHTR2C | |
| SCHEMBL22922689 | 0.70 | GPR84 (0.53) | GPR84FFAR1MAPTHTR2AHTR2C | |
| SCHEMBL7271235 | 0.69 | GPR84 (0.58) | GPR84FFAR1SRCMAPTNR3C1 | |
| SCHEMBL18364645 | 0.68 | GPR84 (0.62) | GPR84FFAR1SRCMAPTNR3C1 | |
| SCHEMBL3343111 | 0.67 | MAPT (0.69) | GPR84FFAR1SRCMAPTNR3C1 | |
| SCHEMBL30040360 | 0.67 | MAPT (0.69) | GPR84FFAR1SRCMAPTNR3C1 | |
| SCHEMBL10717194 | 0.67 | NR3C1 (0.73) | GPR84FFAR1SRCMAPTNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8901336-B2 | Catalysts, methods of making catalysts, and methods of use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-12-02 | — | — | US | disclosed |
| US-8530687-B2 | Catalysts, methods of making catalysts, and methods of use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-09-10 | — | — | US | disclosed |
| US-20130060056-A1 | CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-03-07 | — | — | US | disclosed |
| US-20120059182-A1 | Catalysts, Methods of Makting Catalysts, and Methods of Use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059182-A1 | Catalysts, Methods of Makting Catalysts, and Methods of Use | DKC1, ADCK1, AMD1 | GPR84 3181/4885FFAR1 3853/4885SRC 3423/4885 |
| US-20130060056-A1 | CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE | SOD1, CAT, APEX1 | GPR84 4868/4885FFAR1 4855/4885SRC 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.